Third trimester chemotherapy and neonatal hematopoiesis

descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 1987 English Publisher:Springer Science and Business Media LLCJournal:Cancer Chemotherapy and Pharmacology, volume 19 (issn: 0344-5704, eissn: 1432-0843,

Copyright policy )

Authors: J M, Meador; S A, Armentrout; L M, Slater;

doi: 10.1007/bf00254576

pmid: 3568277

Third trimester chemotherapy and neonatal hematopoiesis

- Summary
- Subjects
- Metrics

Abstract

An 18-year-old woman with severe pancytopenia secondary to chemotherapy given in the third trimester of pregnancy and who delivered an infant with normal peripheral blood counts is reported. The literature is reviewed, and recommendations for the method of delivery in this setting are discussed.

Related Organizations

University of California, Irvine
United States

Keywords

Adolescent, Pancytopenia, Pregnancy Trimester, Third, Infant, Newborn, Sarcoma, Ewing, Fetal Blood, Blood Cell Count, Pregnancy, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Pregnancy Complications, Neoplastic

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	10
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average